Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Excaliard Pharmaceuticals Inc.

Division of Pfizer Inc.
www.excaliard.com

Latest From Excaliard Pharmaceuticals Inc.

Pfizer's Discerning Predator: CEO Ian Read

Metabolic Disorders Cancer

Isis and antisense make gains in 2013

Isis Pharmaceuticals founder, CEO and chairman Stanley Crooke knew it would take decades for antisense to prove itself. And while it's taken a few more years than expected for others to acknowledge the technology's potential, 2013 has been a good year for antisense in general and Isis in particular.

Metabolic Disorders Infectious Diseases

Novo and Novartis funds back $16m Series A for US dermatology startup Thesan

Two pharma-backed venture investment firms put $16 million into a Series A round for a new Southern California dermatology drug company called Thesan Pharmaceuticals, which is run by Gordon Foulkes - the former CEO of San Diego startup Excaliard Pharmaceuticals that Pfizer acquired in 2011 (scripintelligence.com, 23 November 2011).

Orthopedics Inflammation

Biogen Idec To Collaborate With Isis On Treatment For Degenerative Muscle Disorder

The two companies build on an existing partnership in spinal muscular atrophy to address another muscle-wasting disease. For the second time, they’ve arranged an option deal, with milestones built in both before and after licensing.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Musculoskeletal & Connective Tissue Disorders
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • J. Gordon Foulkes, PhD, Pres. & CEO
    Alana McNulty, CFO
    Nicholas M Dean, PhD, CSO
    Gary Gentzkow, MD, CMO
  • Contact Info
  • Excaliard Pharmaceuticals Inc.
    Phone: (760) 431-1850
    2141 Palomar Airport Rd., Ste. 300
    Carlsbad, CA 92011
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register